Vimarsana
Biggest News Aggregation in the World

Ed Esplin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ed Esplin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ed Esplin Today - Breaking & Trending Today

New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines - Vimarsana News

New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines

/PRNewswire/ -- Invitae (OTC:NVTAQ), a leading medical genetics company, today announced eight studies to be presented at the 2024 American Society of Clinical...

Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance - Vimarsana News

Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance

/PRNewswire/ -- Invitae (OTC: NVTA), a leading medical genetics company, today announced new studies to be presented at the American Society of Breast Surgeons...

The best way to prevent the deadliest gynecological cancer is to remove multiple organs - Vimarsana News

The best way to prevent the deadliest gynecological cancer is to remove multiple organs

Prophylactic removal of the ovaries and fallopian tubes is now the recommended way to treat certain people at high risk of ovarian cancer. I’m about to find out what it’s like.

New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology - Vimarsana News

New Research Insights to be Presented by Invitae at the 2023 ASCO Annual Meeting Reinforce the Critical Role of Germline Genetic Testing in Oncology

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced nine studies to be presented at the 2023 American Society of Clinical...

Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer - Vimarsana News

Leading Clinical Experts Across the U.S. Unite to Support Universal Genetic Testing for all Patients with Cancer

/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, joined other clinical experts in releasing a new commentary in Journal of Clinical...